Check out our recent publication about WMH in AD.

Hot off the press! Our group's latest work on daily, brief, remote digital testing to detect the earliest cognitive signs of Alzheimer's disease: doi.org/10.1002/ana.26… Harvard Aging Brain Study BRANCH CognitionPIA Teleneuropsychology Technology and Dementia PIA

Out now in @BrainComms: #DeepLearning vs. #LinearAlgorithms in #stroke #outcome #prediction! Work spearheaded by Anthony Bourached, PhD! 👉 doi.org/10.1093/brainc… Natalia S. Rost, MD, MPH, FAAN Markus D Schirmer MGH Neurology Mass General Research Institute #RostLab #ResilientBrainLab

Extremely happy to announce that I started my lab (Jan 2024) at the NIH as a Stadtman Investigator. Excited to join an amazing scientific community NINDS and NHLBI Bethesda Labs!!! research.ninds.nih.gov/staff-director…

Excited to share our latest paper in Brain, showing low VEGFA and high PGF in plasma were associated with faster cognitive decline in preclinical AD through accelerated tau pathology. Special thanks to co-first author Hyun-Sik and the Harvard Aging Brain Study team and participants!

We are hiring a clinical research coordinator in our clinical trial for individuals at risk of Alzheimer's disease. Interested in neuropsychology, non-invasive brain stimulation and you love working with people? Apply: Mass General Imaging : partners.taleo.net/careersection/…

My lab is recruiting postdocs who are passionate about the genetic and biological mechanisms of epilepsy. Geneticists hoping to learn neuroscience or neuroscientists trying to add genetics to their skillset are welcome to apply. Here is the job ad, plz RT: nature.com/naturecareers/…

Read our recent article on “Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study” JCBFM journals.sagepub.com/doi/abs/10.117…

Looking forward to discussing my postdoctoral work on using remote, digital cognitive testing to examine previously understudied cognitive paradigms such as #practice effects and #intraindividual variability as promising cognitive markers in preclinical #Alzheimer’s disease.

Excited to share our findings on the relationship between CKD, cerebral small vessel disease, and cognitive disorders from Framingham Heart Study NDT academic.oup.com/ndt/advance-ar…

How does vascular dysfunction progress in #CAA? See our pre-print which used a combo of in-vivo two-photon microscopy and MRI to track changes in #vasomotion, #pulsatility, #CBF, #CVR, and more! biorxiv.org/content/10.110…

Blood biomarkers may increase the diversity of research cohorts and clinical trials. How do plasma Aβ42/40 levels and rates of change compare in groups of Black and white research participants? See our new study in Nature Communications: rdcu.be/dMtvc #ENDALZ

📢 I'll be taking a PhD student thru Boston University's Clinical Psych program in the upcoming cycle. If you're considering Grad school and are interested in multicultural neuropsychology, cognitive resilience, aging/Alzheimer's, apply to BU and feel free to contact me with Qs🤩

The Jacobs Lab is ready for #AAIC24! Come and visit us, we have posters presentation and talks throughout the conference:

Super excited about our recent open-access publication @JPAD using the @A4 data. We showed that white matter lesion volume is elevated in people with CAA compared to those without, in preclinical AD. link.springer.com/article/10.142…

I am excited to share our work, out now in The Lancet Neurology, showing cell-based measures of gamma-secretase activity and amyloid production predict clinical, cognitive and biomarker features in autosomal dominant AD. Link to paper: tinyurl.com/ye2a3d5u Alzheimer's Association #AAIC

How does pedometer measured physical activity affect longitudinal tau and cognitive decline in preclinical AD? Importantly, how many steps do we need? Stop by my poster #776 today to find out! #AAIC24 Harvard Aging Brain Study

The Kozberg Lab is officially online! Kozberglab.com

Very proud of our Nat Rev Neurology paper, published today, on the neuromuscular complications of checkpoint inhibitor therapy:

Very excited about the upcoming American Academy of Neurology #BrainHealthSummit 👉 we’ve gone a long way on the road to #BrainHealthForAll 🧠✅ Revisit the AAN #BrainHealth Platform & Position Statement (Neurology 2023) for the definitions, pillars, goals & national #brainhealth vision by 2050 🙌